Join this Podcast to listen to podcasts tailored to adults with Lymphoma. We will discuss current clinical trials and exciting research being done on lymphoma.
Latest Research for Mantle Cell Lymphoma: Understanding Glofitamab with Dr. Craig Portell
Join us as we unpack the latest research on glofitamab for mantle cell lymphoma (MCL). We’ll break down the study, compare glofitamab to current treatment options, and explain what this could mean for patients facing relapsed or refractory MCL.
HealthTree Resources:
News Articles (https://healthtree.org/lymphoma/community/categories/all)
Webinars (https://healthtree.org/lymphoma/community/events?format=webinars&status=past)
HealthTree University (https://healthtree.org/dlbcl/university/modules/yPqDxtbGmHBZa3Dq2jkf)
Connect (https://healthtree.org/lymphoma/connect/group/8wYH4KOs3PIfcuQxLdKU)
Clinical Trial Finder (https://healthtree.org/lymphoma/curehub/)
9 Sept 2025
Early-Stage Research: Exploring the Science Behind a Keto Diet & CAR T Therapy in Lymphoma
This episode explores new preclinical research suggesting that a ketogenic diet may enhance CAR T cell therapy for lymphoma. Join our expert panel as they break down the science, the potential implications, and what’s coming next for a first-in-human clinical trial.
HealthTree Resources:
Connect - Nutrition & Wellness Group (https://healthtree.org/lymphoma/connect/group/BBN6Bmk7wSeU0zaxuHCJ)
Articles - Navigating Your Health (https://healthtree.org/lymphoma/community/categories/navigating-your-health)
Event - Dietary Guidelines for Cancer Prevention After Treatment (https://healthtree.org/lymphoma/community/events/cancer-prevention-dietary-guidelines)
Let me know your thoughts on today's episode! Please share them in a comment or reach out anytime at hannah@healthtree.org (mailto:hannah@healthtree.org).
16 Apr 2025
The D.R.I.V.E. Initiative for Clinical Trial Excellence
D.R.I.V.E. is a strategic framework for promoting representative enrollment in clinical trials. D.R.I.V.E. addresses safety and efficacy concerns that arise when studies are conducted in populations that do not reflect the different patient groups that treatments are intended to serve. Join Maya Birhiray, medical science liaison, to learn more about this initiative and its importance in clinical trials.
HealthTree Resources:
HealthTree CureHub and Clinical Trial Finder (https://healthtree.org/curehub)
Lymphoma Clinical Trial Articles (https://healthtree.org/follicular-lymphoma/community/categories/clinical-trials)
HealthTree Connect Groups
Indy Hematology Education Resources:
The DRIVE Initiative website can be accessed here (https://www.indyhematology.org/review-6wrkb-1).
The DRIVE Score Calculator can be accessed here (https://drive-score-calculator.vercel.app/).
Let me know your thoughts on today's episode! Please share them in a comment or reach out anytime at hannah@healthtree.org (mailto:hannah@healthtree.org).
17 Mar 2025
TRANSCEND FL Trial Updates with Dr. Manali Kamdar
TRANSCEND FL is a global trial assessing the efficacy and safety of the CAR T cell therapy lisocabtagene maraleucel in patients with relapsed or refractory follicular lymphoma. Join Dr. Kamdar, the lead investigator for this trial at University of Colorado Cancer Center, for this podcast to learn more. Feel free to email me with thoughts or questions on this podcast at hannah@healthtree.org (mailto:hannah@healthtree.org).
For additional CAR T resources, see below.
HealthTree University:
What is CAR-T therapy and how is this drug class used to treat follicular lymphoma? (https://healthtree.org/follicular-lymphoma/university/courses/MULnyiUAIFFSjjGpJ0zZ)
What is some of the most promising research being done for follicular lymphoma? (https://healthtree.org/follicular-lymphoma/university/courses/nezuou6O4WHJXiZVOQFJ)
What are my options for treating follicular lymphoma? (https://healthtree.org/follicular-lymphoma/university/courses/a8ZgfUsPK12r8XEoDVpn)
News Articles:
Liso-cel CAR T-Cell Therapy (https://healthtree.org/follicular-lymphoma/community/articles/liso-cel-car-t-follicular-lymphoma-fda)
CAR T-cell Therapy for Follicular Lymphoma (https://healthtree.org/follicular-lymphoma/community/articles/new-car-t-therapy-for-fl)
101 Pages:
What are the Treatments for Follicular Lymphoma? (https://healthtree.org/follicular-lymphoma/community/what-are-treatments-for-follicular-lymphoma)
28 Feb 2025
Follicular Lymphoma Progress in 2024
Listen to this podcast with Dr. Carla Casulo and Judith Trotman to hear about some of the most exciting advancements for follicular lymphoma from the 2024 ASH Conference.
ASH News Articles:
What is ASH? https://healthtree.org/follicular-lymphoma/community/articles/what-is-the-ash-conference-dlbcl (https://healthtree.org/follicular-lymphoma/community/articles/what-is-the-ash-conference-dlbcl)
FL Specialist Insights https://healthtree.org/follicular-lymphoma/community/articles/ash-24-fl-specialists-insights-new-treatments (https://healthtree.org/follicular-lymphoma/community/articles/ash-24-fl-specialists-insights-new-treatments)
Best of ASH 2024: https://healthtree.org/follicular-lymphoma/community/articles/ash-24-the-best-of-it-all (https://healthtree.org/follicular-lymphoma/community/articles/ash-24-the-best-of-it-all)
ASH Videos:
https://healthtree.org/blood-cancer/university/courses/klLCY3gkYKWHQDry3bkZ (https://healthtree.org/blood-cancer/university/modules/V33aLCfmYhGeYz3iLH8b)
Let me know your thoughts on today's episode! Feel free to email me with questions, comments, or insights at hannah@healthtree.org (mailto:hannah@healthtree.org).
24 Feb 2025
Latest Advancements in CAR-T Therapy with Dr. Ehsan Malek
Listen to this pre-recorded podcast to learn from Dr. Ehsan Malek, a hematologist oncologist at Roswell Park, about some of the major breakthroughs in CAR T therapy in 2024 and what is on the horizon in 2025.
3 May 2024
DLBCL and Follicular Lymphoma Clinical Trials at MD Anderson
Dr. Strati shares about trials happening at MD Anderson for DLBCL and follicular lymphoma. This includes the following:
Two completed follicular lymphoma trials:
Phase I study of evorpacept and R2 in relapsed indolent B-NHL
Phase 2 study of acalabrutinib and R2 in previously untreated indolent B-NHL
One ongoing DLBCL trial:
Phase 2 study of loncastuximab as consolidation after CART in DLBCL
One upcoming DLBCL trial:
Phase 2 study of emapalaumab for the treatment of persistent severe cytopenia after CART in DLBCL
11 Apr 2024
Targeted Therapy Combinations: VVIP, VIPOR, and VIPOR-P Clinical Trials
Dr. Melani discusses the latest updates from the VVIP, VIPOR, and VIPOR-P studies, which are clinical trials for non-Hodgkin's lymphoma. The goal of these studies is to improve the outcome for patients with relapsed or refractory lymphomas by using targeted therapy combinations. Targeted therapies block specific proteins that cancer cells need to grow and survive. The conversation also discusses these three clinical trials' design and treatment protocols.
1 Mar 2024
PET Biomarkers in Lymphoma
Defining and tracking progression/remission in follicular lymphoma patients can be subjective and complicated. In this episode, we are joined by Dr. Juan Pablo Alderuccio. Dr. Alderuccio recently published his research (https://pubmed.ncbi.nlm.nih.gov/37460635/) on PET-based biomarkers in lymphoma patients. His research aims to give patients a more accurate knowledge of their lymphoma prognosis.
Thank you to our episode sponsor, Regeneron.
Podcast Authority Score: 2 / 100
A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.
Quality
4
Social presence
0
YouTube
0
Engagement
0
Contact HealthTree Podcast for Follicular Lymphoma
Guest appearances
Does not typically book guests
Based on episode analysis; this does not confirm that the show is currently accepting guests.
Host of HealthTree Podcast for Follicular Lymphoma?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
